By Abigail W. Adams
Portland, Me., July 11 – Healios K.K. priced ¥5 billion in three-year convertible bonds on Thursday at par with a coupon of 0% and an initial conversion premium of 15% in a Regulation S offering, according to a company announcement.
The conversion price for the bonds is ¥1,711. They will be redeemed at par at their maturity.
The bonds priced concurrently with a ¥3 billion offering of common stock which priced at ¥1,540 per share.
Net proceeds are expected to be ¥7,633,000,000. Proceeds will be used for the development of the company’s pipeline, ¥2.5 billion will be used to establish the Venture Capital Fund and ¥1.6 billion will be used for general corporate purposes.
Healios K.K. is a Tokyo-based pharmaceutical company.
| Issuer: | Healios K.K.
|
| Securities: | Convertible bonds
|
| Amount: | ¥5 billion
|
| Maturity: | 2022
|
| Coupon: | 0%
|
| Price: | Par
|
| Yield: | 0%
|
| Conversion premium: | 15%
|
| Conversion price: | ¥1,711
|
| Pricing date: | July 11
|
| Distribution: | Regulation S
|
| Stock symbol: | TYO: 4593
|
| Stock price: | ¥1,561
|
| Market capitalization: | ¥76.93 billion
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
